Profile

Paul A.  Dawson, Ph.D.

Paul A. Dawson, Ph.D.

Professor, Gastroenterology
Contact Information
Appointment:
336-713-7777
Office:
336-713-7777
Fax:
336-713-7322
Education & Training
  BS University of Florida 1981
  PhD SUNY-Stony Brook 1986
Fellowship University of Texas Southwestern Medical Center 1990
Memberships
Aasld
American Gastroenterological Association
Aha - Council On Arteriosclerosis
Gastroenterology Research Group
Paul A.  Dawson, Ph.D.

Paul A. Dawson, Ph.D.

Professor, Gastroenterology
Contact Information
Appointment:
336-713-7777
Office:
336-713-7777
Fax:
336-713-7322
Research Interests
critical/intensive care medici , drugs/therapeutic agents pharm , maternal & child health , metabolism , radiology/imaging
Recent Publications
Dawson PA. Role of the intestinal bile acid transporters in bile acid and drug disposition. Handb Exp Pharmacol. 2011; 201():169-203.


Tang W, Jia L, Ma Y, Xie P, Haywood J, Dawson PA, Li J, Yu L. Ezetimibe restores biliary cholesterol excretion in mice expressing Niemann-Pick C1-Like 1 only in liver. Biochim Biophys Acta. 2011; 1811(9):549-555.

Ho RH, Leake BF, Urquhart BL, Gregor JC, Dawson PA, Kim RB. Functional characterization of genetic variants in the apical sodium-dependent bile acid transporter (ASBT; SLC10A2). J Gastroenterol Hepatol. 2011; 26(12):1740-1748.

Dawson PA. Bile secretion and the enterohepatic circulation. In: Feldman M, Friedman LS, Brandt LJ, eds. Sleisenger and Fordtran's gastrointestinal and liver disease: pathophysiology/diagnosis/management. 9th ed. Philadelphia: Saunders/Elsevier; 2010: 1075-1088.


Dawson PA, Hubbert ML, Rao A. Getting the mOST from OST: Role of organic solute transporter, OSTalpha-OSTbeta, in bile acid and steroid metabolism. Biochim Biophys Acta. 2010; 1801(9):994-1004.

Beuling E, Kerkhof IM, Nicksa GA, Giuffrida MJ, Haywood J, aan de Kerk DJ, Piaseckyj CM, Pu WT, Buchmiller TL, Dawson PA, et al. Conditional Gata4 deletion in mice induces bile acid absorption in the proximal small intestine. Gut. 2010; 59(7):888-895.

Lan TA, Haywood JH, Rao A, Dawson PA. Inactivation of organic solute transporter (OST)alpha alters bile acid homeostasis via the FXR-FGF15 pathway [abstract]. Hepatology. 2010; 52(4 Suppl):431A.

Miyata M, Matsuda Y, Nomoto M, Takamatsu Y, Sato N, Hamatsu M, Dawson PA, Gonzalez FJ, Yamazoe Y. Cholesterol feeding prevents hepatic accumulation of bile acids in cholic acid-fed farnesoid X receptor (FXR)-null mice: FXR-independent suppression of intestinal bile acid absorption. Drug Metab Dispos. 2009; 37(2):338-344.

Dawson PA, Lan T, Rao A. Bile acid transporters. J Lipid Res. 2009; 50(12):2340-2357.

Lan T, Rao A, Haywood J, Davis CB, Han C, Garver E, Dawson PA. Interaction of macrolide antibiotics with intestinally expressed human and rat organic anion-transporting polypeptides. Drug Metab Dispos. 2009; 37(12):2375-2382.

Rao A, Haywood J, Dawson PA. Role of the organic solute transporter Ost alpha-Ost beta in intestinal basolateral bile acid transport and bile acid homeostasis. In: Keppler D, Beuers U, Steihl A, Trauner M, eds. Bile acid biology and therapeutic actions. Proceedings of Falk Symposium 165; 2008 June 13-14; Amsterdam (The Netherlands). Dordrecht (The Netherlands): Springer; 2009: 69-75.

Rao A, Haywood J, Craddock AL, Belinsky MG, Kruh GD, Dawson PA. The organic solute transporter alpha-beta, Ostalpha-Ostbeta, is essential for intestinal bile acid transport and homeostasis. Proc Natl Acad Sci U S A. 2008; 105(10):3891-3896.

Haywood J, Rao A, Dawson P. Inactivation of the ileal bile acid transporter reduces ileal fibroblast growth factor 15 expression and limits atherosclerosis in apolipoprotein E and LDL receptor null mice [abstract]. Arterioscler Thromb Vasc Biol. 2008; 28(6):e-121.

Garver E, Hugger ED, Shearn SP, Rao A, Dawson PA, Davis CB, Han C. Involvement of intestinal uptake transporters in the absorption of azithromycin and clarithromycin in the rat. Drug Metab Dispos. 2008; 36(12):2492-2498.

Beuling E, Kerkhof IM, Piaseckyj CM, Dawson PA, Pu WT, Grand RJ, Krasinski SD. The absence of GATA4 in the distal small intestine defines the ileal phenotype [abstract]. Gastroenterology. 2008; 134(4 Suppl 1):A83-A84.

Rao A, Haywood J, Craddock AL, Belinsky MG, Kruh GD, Dawson PA. The basolateral transporter Ost alpha-Ost beta is essential for intestinal bile acid absorption and homeostasis [abstract]. Hematology. 2007; 46(4 Suppl 1):271A.

Jung D, Inagaki T, Gerard RD, Dawson PA, Kliewer SA, Mangelsdorf DJ, Moschetta A. FXR agonists and FGF15 reduce fecal bile acid excretion in a mouse model of bile acid malabsorption. J Lipid Res. 2007; 48(12):2693-2700.

Rao A, Haywood J, Craddock AL, Dawson PA. Molecular mechanism of intestinal basolateral bile acid transport. In: Keppler D, Beuers U, Leuschner U, Stiehl A, Trauner M, Paumgartner G, eds. Bile acids: biological actions and clinical relevance. Proceedings of the Falk Symposium 155; 2006 Oct 6-7; Freiberg (Germany). Dordrecht (The Netherlands): Springer; 2007: 76-84.

Dawson PA. Bile secretion and the enterohepatic circulation. In: Feldman M, Friedman LS, Brandt LJ, Sleisenger MH, eds. Sleisenger & Fordtran's gastrointestinal and liver disease, vol 1. 8th ed. Philadelphia (PA): Saunders Elsevier; 2006: 1369-1385.

Neimark E, Chen F, Li X, Magid MS, Alasio TM, Frankenberg T, Sinha J, Dawson PA, Shneider BL. c-Fos is a critical mediator of inflammatory-mediated repression of the apical sodium-dependent bile acid transporter. Gastroenterology. 2006; 131(2):554-567.

Splinter PL, Lazaridis KN, Dawson PA, LaRusso NF. Cloning and expression of SLC10A4, a putative organic anion transport protein. World J Gastroenterol. 2006; 12(42):6797-6805.

Montagnani M, Abrahamsson A, Galman C, Eggertsen G, Marschall H-U, Ravaioli E, Einarsson C, Dawson PA. Analysis of ileal sodium/bile acid cotransporter and related nuclear receptor genes in a family with multiple cases of idiopathic bile acid malabsorption. World J Gastroenterol. 2006; 12(47):7710-7714.
All Publications

For a listing of recent publications, refer to PubMed, a service provided by the National Library of Medicine.

For a list of earlier publications, visit the Carpenter Library Publication Search.

Paul A.  Dawson, Ph.D.

Paul A. Dawson, Ph.D.

Professor, Gastroenterology
Contact Information
Appointment:
336-713-7777
Office:
336-713-7777
Fax:
336-713-7322

Current Research:

Bile acids, cholesterol metabolism, molecular cloning, gene expression and regulation, molecular genetics

Molecular Genetics of Ileal Bile Acid Transporter. My lab identified and cloned the human ileal bile acid transporter cDNA and gene. These probes are being used to identify dysfunctional mutations in patients with bile acid malabsorption. Various classes of dysfunctional mutations in the ileal bile acid transporter gene have been identified. In addition to null mutations (i.e., splicing defects), we have also identified missense mutations that interfere with bile acid transporter processing and mechanism of action. The Class 2 mutations cause misfolding and ER retention of the transporter. More interesting are the Class 3 and 4 mutations that block bile acid transport at the substrate binding and solute translocation steps. The actions of these mutations are being studied to gain insight into the molecular mechanism of sodium-coupled solute transport. The association of these mutations with other gastrointestinal and lipid metabolism disorders including gallstone disease, irritable bowel syndrome, hypocholesterolemia, and hypertriglyceridemia is currently being investigated.

Ileal Bile Acid Transporter Biology. In addition to the ileum, the ileal bile acid transporter is expressed in the proximal tubules of the kidney and in the cholangiocytes lining the bile ducts. The role of the transporter in the ileum and kidney is the quantitative reclamation of bile acids. However, its role in bile duct epithelium is unknown. We are generating an ileal bile acid transporter knockout mouse as a model to further understand the physiological role of the transporter in different tissues.

Intracellular Lipid Transport. The transcellular transport of bile acids is a defined process that involves uptake across the apical membrane, trafficking to the basolateral membrane and secretion across the basolateral membrane. Currently, we have identified and cloned cDNAs for the apical membrane transporter responsible for the initial uptake of bile acids, and the cytoplasmic binding protein thought to be responsible for the transcellular transport. We are devising expression-cloning strategies to identify additional bile acid transporters as well as the basolateral membrane transporter. Using the cloned transporters in polarized cells, the entire pathway can be reconstituted and analyzed. This model system should yield insight into more complex pathways for intracellular lipid trafficking.

PA Dawson Figure1

FIGURE LEGEND: Disruption of the Ileal Bile Acid Transporter Gene in Mice. A) This figure shows the structure of the mouse ileal bile acid transporter gene (slc10a2), the targeting vector, as well as the predicted disrupted gene. Exons are numbered and indicated by the boxes. TK, viral thymidine kinase gene; NEO, neomycin resistance gene. B) The lower panel shows the results of PCR analysis of the ileal bile acid transporter gene in wild type mice (+/+) or mice that are heterozygous (+/-) or homozygous (-/-) for disruption of slc10a2. The results are shown for a Neo-specific probe (Neo gene), the wild type Slc10a2 gene, or lecithin cholesterol acyl-transferase (LCAT) as control.

Publications:

Link to Coy C. Carpenter Library Faculty Publication Database

 

Last Updated 3/13/2012
Quick Reference
Request an Appointment
New Patients
336-716-WAKE
888-716-WAKE
Existing patients may contact the clinic directly.
Locate Faculty

e.g., "allergy," "diabetes"

US News Best Hospital AwardANCC Magnet Association AwardBest Doctors 2011-2012 AwardConsumer Choice #1 Award 2011-2102US News Best Medical Schools 2011 Award

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.